Article
Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.
Clinical pharmacology and therapeutics - 1 Jan 2008
Lee C R, North K E, Bray M S, Couper D J, Heiss G, Zeldin D C
Abstract excerpt
Cyclooxygenase-derived prostaglandins modulate cardiovascular disease risk. We genotyped 2212 Atherosclerosis Risk in Communities study participants (1,023 incident coronary heart disease (CHD) cases; 270 incident ischemic stroke cases; 919 non-cases) with available DNA for polymorphisms in PTGS1 and PTGS2. Using a case-cohort design, associations between genotype and CHD or stroke risk were evaluated using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
